You are here

  • Home
  • Archive
  • Volume 20, Issue 5
  • Ezetimibe provides incremental reduction in risk for cardiovascular events and need for revascularisation following an acute coronary syndrome

Article metrics

Article menu
Download PDFPDF
Therapeutics/Prevention
Randomised controlled trial
Ezetimibe provides incremental reduction in risk for cardiovascular events and need for revascularisation following an acute coronary syndrome

 

Online download statistics by month:

Online download statistics by month: August 2015 to March 2024

AbstractFullPdf
Aug 20151061316
Sep 2015126919
Oct 2015811012
Nov 2015881854
Dec 20155913
Jan 20163534
Feb 20162613
Mar 2016711
Apr 20161010
May 20163100
Jun 20161003
Jul 2016600
Aug 20161610
Sep 20161634
Oct 20163522
Nov 20161312
Dec 20162100
Jan 20172101
Feb 20171812
Mar 20171320
Apr 20172200
May 20171910
Jun 20171411
Jul 20172200
Aug 20171911
Sep 20172821
Oct 20174600
Nov 20173000
Dec 20171411
Jan 20183511
Feb 2018800
Mar 20183540
Apr 20184320
May 20183022
Jun 20187801
Jul 20181700
Aug 20181800
Sep 2018610
Oct 20182611
Nov 20183700
Dec 20183411
Jan 20193700
Feb 20193100
Mar 20191500
Apr 20191310
May 20191900
Jun 2019802
Jul 20193052
Aug 20191000
Sep 20192400
Oct 20191412
Nov 20191900
Dec 20192100
Jan 20202810
Feb 20202910
Mar 2020300
Apr 20201000
May 20201300
Jun 20201500
Jul 20201711
Aug 20201101
Sep 20203900
Oct 20201900
Nov 20201000
Dec 20201600
Jan 20212620
Feb 20212120
Mar 20212000
Apr 2021800
Jun 2021100
Sep 2021220
Oct 20212602
Nov 20213300
Dec 20216210
Jan 20228071
Feb 20224800
Mar 20229910
Apr 20225511
May 20226600
Jun 20228730
Jul 20225412
Aug 20229120
Sep 20229430
Oct 20226701
Nov 20227910
Dec 20224900
Jan 20236900
Feb 20239200
Mar 20232400
Apr 20231800
May 20231511
Jun 20232400
Jul 20231400
Aug 20231002
Sep 20231000
Oct 20231600
Nov 20232810
Dec 20232210
Jan 20241201
Feb 20246400
Mar 20242921
Total3285126156